Abstract: A semiconductor device includes: first and second active regions extending in a first direction and separated by a gap relative to a second direction substantially perpendicular to the first direction; and gate structures correspondingly over the first and second active regions, the gate structures extending in the second direction; and each of the gate structures extending at least unilaterally substantially beyond a first side of the corresponding first or second active region that is proximal to the gap or a second side of the corresponding first or second active region that is distal to the gap; and some but not all of the gate structures also extending bilaterally substantially beyond each of the first and second sides of the corresponding first or second active region.

Abstract: A thrombectomy device (100) comprising an aspiration pump (10), a catheter (20) and a valve (30) is provided. The aspiration pump (10) is for providing an negative pressure continuously or by interval. The catheter (20) having a distal end (23), mid portion (22) and a proximal end (21) and defining a longitudinal axis. The valve (30) connects between the aspiration pump (10) and the proximal end (21) of the catheter (20) or connects to the catheter (20). Wherein, the catheter (20) comprises at least one elastic area (24), which is compressed along the longitudinal axis in response to application of the negative pressure and expanded along the longitudinal axis in response to relieve of the negative pressure.

Abstract: A thrombus removal device (100) comprising a catheter (10), at least one valve (20), and a shaft (30) is provided. The catheter (10) has a proximal end (12) and a distal end (11), and defines a longitudinal axis. The at least one valve (20) is positioned and movable longitudinally inside the catheter (10). The shaft (30) is connected with the proximal end (12) of the catheter (10), and comprises a driving mechanism and a wire (34). Wherein, the wire (34) is connected to the driving mechanism at one end and connected to the at least one valve (20) at an opposite end. The driving mechanism is configured to create a sudden movement of the at least one valve (20) toward the proximal end (12) of the catheter (10). By using the thrombus removal device (100), thrombus can be removed from the body of a subject more efficiently.

Abstract: Embodiments of the disclosure may include a pressure sensitive hydrogel composition. The composition may include a liquid solvent, a polymer, and an acid gas. The composition may be capable of having a fluid phase in which the acid gas is dissolved in the solvent and the polymer is dissolved in the solvent, and the composition may be capable of having a gel phase in which the acid gas is not dissolved in the liquid solvent and the polymer is precipitated out of the solvent. The composition may also include a chemical compound or a pharmaceutical agent that can be released after the composition is delivered to a target tissue region.

Abstract: A syringe includes a sleeve and a pressure vessel with high pressure fluid therein. The sleeve further comprises a sleeve piston. As the high pressure vessel contacts the sleeve piston, and a bump on the sleeve piston destroys the airtight status of the high pressure vessel. While the seal of the high pressure vessel is removed, the compressed fluid flows into the sleeve through the opening of the high pressure vessel and the hole of the sleeve piston. When the closed end of the sleeve moves closer to the closed end of the sleeve piston, the fluid in the sleeve is pressed and flows out of the sleeve through the sleeve hole of the sleeve.

Abstract: A syringe includes a sleeve and a pressure vessel with high pressure fluid therein. The sleeve further comprises a sleeve piston. As the high pressure vessel contacts the sleeve piston, and a bump on the sleeve piston destroys the airtight status of the high pressure vessel. While the seal of the high pressure vessel is removed, the compressed fluid flows into the sleeve through the opening of the high pressure vessel and the hole of the sleeve piston. When the closed end of the sleeve moves closer to the closed end of the sleeve piston, the fluid in the sleeve is pressed and flows out of the sleeve through the sleeve hole of the sleeve.

Abstract: Embodiments of the disclosure may include a pressure sensitive hydrogel composition. The composition may include a liquid solvent, a polymer, and an acid gas. The composition may be capable of having a fluid phase in which the acid gas is dissolved in the solvent and the polymer is dissolved in the solvent, and the composition may be capable of having a gel phase in which the acid gas is not dissolved in the liquid solvent and the polymer is precipitated out of the solvent. The composition may also include a chemical compound or a pharmaceutical agent that can be released after the composition is delivered to a target tissue region.

Abstract: One embodiment provides a method for enzymatic treatment, including the steps of forming a closed space on a local tissue area with a device and infusing an enzyme solution into the closed space for enzymatic treatment. The method according to the embodiment is capable of treating the local tissue area with enzymes for enhancing cell proliferation in the treated tissue area and preventing damage of the adjacent normal tissues. A device and kit used for the method are also provided.

Abstract: The disclosure provides a method for crosslinking a colloid, including: (a) providing a colloid solution; (b) adding a crosslinking agent and solid particles to the colloid solution, wherein the amount of solid particles added is enough to convert the colloid solution into a solid mixture, and wherein a crosslinking reaction proceeds in the solid mixture; and (c) removing the solid particles from the solid mixture.

Abstract: One embodiment provides a method for enzymatic treatment, including the steps of forming a closed space on a local tissue area with a device and infusing an enzyme solution into the closed space for enzymatic treatment. The method according to the embodiment is capable of treating the local tissue area with enzymes for enhancing cell proliferation in the treated tissue area and preventing damage of the adjacent normal tissues. A device and kit used for the method are also provided.

Abstract: One embodiment provides a method for enzymatic treatment, including the steps of forming a closed space on a local tissue area with a device and infusing an enzyme solution into the closed space for enzymatic treatment. The method according to the embodiment is capable of treating the local tissue area with enzymes for enhancing cell proliferation in the treated tissue area and preventing damage of the adjacent normal tissues. A device and kit used for the method are also provided.

Abstract: One embodiment provides a method for enzymatic treatment, including the steps of forming a closed space on a local tissue area with a device and infusing an enzyme solution into the closed space for enzymatic treatment. The method according to the embodiment is capable of treating the local tissue area with enzymes for enhancing cell proliferation in the treated tissue area and preventing damage of the adjacent normal tissues. A device and kit used for the method are also provided.

Abstract: The disclosure provides a method for crosslinking a colloid, including: (a) providing a colloid solution; (b) adding a crosslinking agent and solid particles to the colloid solution, wherein the amount of solid particles added is enough to convert the colloid solution into a solid mixture, and wherein a crosslinking reaction proceeds in the solid mixture; and (c) removing the solid particles from the solid mixture.

Abstract: A dental retrograde-filling material process, comprising the steps of: taking 3:1 mole ratio of a calcium oxide and a silicon dioxide mixes a 1˜5 w.t. % cobalt oxide at 1200˜1800 degree Celsius temperature to get a A-product including a tricalcium silicate, a dicalcium silicate and a containing cobalt composition; taking 3:1 mole ratio of a calcium oxide and an aluminum oxide at 1200˜1800 degree Celsius temperature reacts a B-product including a tricalcium aluminate; taking 4:1:1 mole ratio of a calcium oxide, an aluminum oxide and a ferric oxide at 1200˜1800 degree Celsius temperature reacts a C-product including a calcium alminoferrite; and mixing the A-product, B-product and C-product are the retrograde-filling material. The dental retrograde-filling material mixes of taking 8:1:1 mole ratio of said tricalcium silicate, dicalcium silicate and containing cobalt composition, tricalcium aluminate and calcium alminoferrite.